Physician

Chukwuemeka Ogbonnaya Chima, MD

According to 2025 Medicare claims, Chukwuemeka Chima, MD (NPI: 1962494377) practices infectious disease in the Fayetteville, NC market, with the plurality of this provider's patient population coming from Cumberland, NC. This provider's primary affiliated billing organization is CID PA (NPI: 1588805188; TIN: 030603235) and primary practice location at 28304-3424.

Chima's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 638 traditional Medicare patients, billed 31,206 HCPCS/CPT codes, and received $387,536 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,817 prescription claims across 343 beneficiaries totaling $2,999,716 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2021 DME data shows 11 claims. Open Payments data shows 138 records totaling $3,242. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $401,242 to $387,536. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,396,598 and ending at $2,999,716. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,119	45,641	$401,242
2016	1,488	30,074	$509,789
2017	1,545	248,665	$966,379
2018	1,310	328,175	$902,670
2019	1,028	253,796	$932,837
2020	1,019	392,151	$834,185
2021	913	157,017	$592,553
2022	741	144,940	$494,598
2023	667	118,020	$512,009
2024	638	31,206	$387,536

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	189	1,537	$1,396,598
2016	215	1,443	$1,345,973
2017	223	1,345	$1,722,305
2018	196	1,213	$1,288,062
2019	241	1,466	$1,548,507
2020	232	1,198	$1,107,126
2021	235	1,348	$1,227,200
2022	310	1,582	$1,893,550
2023	268	1,085	$1,414,087
2024	343	1,817	$2,999,716

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$503
2021	N/R	11	$62
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	347	432	$127
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	152	186	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	243	721	$91
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	300	730	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	243	589	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	194	5,820	$801,984
Dovato	Dolutegravir Sodium/Lamivudine	125	3,732	$388,271
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	44	1,320	$213,138
Cabenuva	Cabotegravir/Rilpivirine	24	1,064	$174,311
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	44	1,320	$166,789

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	138	$3,242	ViiV Healthcare Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chukwuemeka Ogbonnaya Chima, MD?

Tedicare shows public-source Medicare data for Chukwuemeka Ogbonnaya Chima, MD (NPI 1962494377), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chukwuemeka Ogbonnaya Chima, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chukwuemeka Ogbonnaya Chima, MD?

Chukwuemeka Ogbonnaya Chima, MD is linked to CID PA (billing NPI 1588805188) in the available physician profile data.

Does Chukwuemeka Ogbonnaya Chima, MD have Open Payments data?

Chukwuemeka Ogbonnaya Chima, MD has 138 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.